Sageworth Trust Company of South Dakota’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-68
Closed -$1K – 497
2022
Q2
$1K Hold
68
– – ﹤0.01% 504
2022
Q1
$1K Sell
68
-311
-82% -$6.54K ﹤0.01% 543
2021
Q4
$13K Buy
+379
New +$14.8K 0.02% 315

Other funds holding NEO

Sageworth Trust Company of South Dakota's NEO Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of NeoGenomics (NEO) in Q3 2022, closing a stake of 68 shares — an estimated $1K sold.

Sageworth Trust Company of South Dakota first reported a position in NEO in Q4 2021 and held it in 3 quarters. The position peaked at $13K in Q4 2021. 245 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining NeoGenomics position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 68 NeoGenomics shares in Q3 2022, an estimated $1K.
  • Sageworth Trust Company of South Dakota first reported a position in NeoGenomics in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's NeoGenomics position peaked at $13K in Q4 2021.
  • 245 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.